Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
This report elaborates on the current development of the Antirheumatics Pharmaceutical industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis International AG
Pfizer
Bristol-Myers Squibb
Amgen
Eli Lilly and Company
Johnson & Johnson
Merck
UCB SA
Roche Holding AG
By Type:
Non-Steroidal Anti-Inflammatory Drugs
Immunological Preparation
Slow Acting Drug
Steroidal Anti-Inflammatory Drugs
By Application:
Hospital and Clinic
Pharmaceutical Industry
Other
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Antirheumatics Pharmaceutical Market Overview 2018-2029
-
1.1 China Antirheumatics Pharmaceutical Industry Development Overview
-
1.2 China Antirheumatics Pharmaceutical Industry Development History
-
1.3 China Antirheumatics Pharmaceutical Industry Market Size (2018-2029)
-
1.4 China Antirheumatics Pharmaceutical Market Analysis by Type from Production Side
-
1.4.1 China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)
-
1.4.2 China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Immunological Preparation (2018-2029)
-
1.4.3 China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Slow Acting Drug (2018-2029)
-
1.4.4 China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Steroidal Anti-Inflammatory Drugs (2018-2029)
-
1.5 China Antirheumatics Pharmaceutical Market Analysis by Application from Consumption End
-
1.5.1 China Antirheumatics Pharmaceutical Sales Volume, Sales Value and Growth Rate of Hospital and Clinic (2018-2029)
-
1.5.2 China Antirheumatics Pharmaceutical Sales Volume, Sales Value and Growth Rate of Pharmaceutical Industry (2018-2029)
-
1.5.3 China Antirheumatics Pharmaceutical Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.6 China Antirheumatics Pharmaceutical Market Analysis by Region
-
1.6.1 North China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
Chapter 2 China Antirheumatics Pharmaceutical Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Antirheumatics Pharmaceutical Market Status and Competition at home and abroad in 2023
-
2.2.2 China Antirheumatics Pharmaceutical Market Status and Competition Analysis in 2023
-
2.2.3 China Antirheumatics Pharmaceutical Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Antirheumatics Pharmaceutical Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Antirheumatics Pharmaceutical Industry Development
Chapter 3 Antirheumatics PharmaceuticalIndustry Chain Analysis
-
3.1 Antirheumatics Pharmaceutical Industry Chain
-
3.2 Antirheumatics Pharmaceutical Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Antirheumatics Pharmaceutical Market
-
3.3 Antirheumatics Pharmaceutical Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Antirheumatics Pharmaceutical Market
Chapter 4 China Antirheumatics Pharmaceutical Market, by Type
-
4.1 China Antirheumatics Pharmaceutical Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Antirheumatics Pharmaceutical Total Production Volume and Growth Rate from Production Side
-
4.5 China Antirheumatics Pharmaceutical Production Volume and Growth Rate, by Type
-
4.5.1 China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs
-
4.5.2 China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Immunological Preparation
-
4.5.3 China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Slow Acting Drug
-
4.5.4 China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Steroidal Anti-Inflammatory Drugs
Chapter 5 China Antirheumatics Pharmaceutical Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Antirheumatics Pharmaceutical Total Market Size and Growth Rate from Consumption End
-
5.5 China Antirheumatics Pharmaceutical Market Size and Growth Rate, by Application
-
5.5.1 China Antirheumatics Pharmaceutical Market Size and Growth Rate of Hospital and Clinic
-
5.5.2 China Antirheumatics Pharmaceutical Market Size and Growth Rate of Pharmaceutical Industry
-
5.5.3 China Antirheumatics Pharmaceutical Market Size and Growth Rate of Other
Chapter 6 China Antirheumatics Pharmaceutical Market, by Region
-
6.1 China Antirheumatics Pharmaceutical Production Volume and Production Value, by Region
-
6.2 China Antirheumatics Pharmaceutical Sales Volume and Sales Value, by Region
Chapter 7 North China Antirheumatics Pharmaceutical Market Analysis
-
7.1 North China Antirheumatics Pharmaceutical Market, by Type
-
7.2 North China Antirheumatics Pharmaceutical Market, by Application
Chapter 8 Central China Antirheumatics Pharmaceutical Market Analysis
-
8.1 Central China Antirheumatics Pharmaceutical Market, by Type
-
8.2 Central China Antirheumatics Pharmaceutical Market, by Application
Chapter 9 South China Antirheumatics Pharmaceutical Market Analysis
-
9.1 South China Antirheumatics Pharmaceutical Market, by Type
-
9.2 South China Antirheumatics Pharmaceutical Market, by Application
Chapter 10 East China Antirheumatics Pharmaceutical Market Analysis
-
10.1 East China Antirheumatics Pharmaceutical Market, by Type
-
10.2 East China Antirheumatics Pharmaceutical Market, by Application
Chapter 11 Northeast China Antirheumatics Pharmaceutical Market Analysis
-
11.1 Northeast China Antirheumatics Pharmaceutical Market, by Type
-
11.2 Northeast China Antirheumatics Pharmaceutical Market, by Application
Chapter 12 Southwest China Antirheumatics Pharmaceutical Market Analysis
-
12.1 Southwest China Antirheumatics Pharmaceutical Market, by Type
-
12.2 Southwest China Antirheumatics Pharmaceutical Market, by Application
Chapter 13 Northwest China Antirheumatics Pharmaceutical Market Analysis
-
13.1 Northwest China Antirheumatics Pharmaceutical Market, by Type
-
13.2 Northwest China Antirheumatics Pharmaceutical Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis International AG
-
14.1.1 Novartis International AG Company Profile
-
14.1.2 Novartis International AG Antirheumatics Pharmaceutical Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pfizer
-
14.2.1 Pfizer Company Profile
-
14.2.2 Pfizer Antirheumatics Pharmaceutical Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Profile
-
14.3.2 Bristol-Myers Squibb Antirheumatics Pharmaceutical Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Antirheumatics Pharmaceutical Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Profile
-
14.5.2 Eli Lilly and Company Antirheumatics Pharmaceutical Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Profile
-
14.6.2 Johnson & Johnson Antirheumatics Pharmaceutical Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Merck
-
14.7.1 Merck Company Profile
-
14.7.2 Merck Antirheumatics Pharmaceutical Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 UCB SA
-
14.8.1 UCB SA Company Profile
-
14.8.2 UCB SA Antirheumatics Pharmaceutical Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Roche Holding AG
-
14.9.1 Roche Holding AG Company Profile
-
14.9.2 Roche Holding AG Antirheumatics Pharmaceutical Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Antirheumatics Pharmaceutical Industry Research Conclusions
-
15.2 Antirheumatics Pharmaceutical Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Antirheumatics Pharmaceutical Industry Market Size (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Immunological Preparation (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Slow Acting Drug (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Production Volume, Production Value and Growth Rate of Steroidal Anti-Inflammatory Drugs (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Sales Volume, Sales Value and Growth Rate of Hospital and Clinic (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Sales Volume, Sales Value and Growth Rate of Pharmaceutical Industry (2018-2029)
-
Figure China Antirheumatics Pharmaceutical Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure North China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure Central China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure South China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure East China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Antirheumatics Pharmaceutical Market Size and Growth Rate from 2018-2029
-
Figure Antirheumatics Pharmaceutical Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Antirheumatics Pharmaceutical Market Share by Type in 2018
-
Figure China Antirheumatics Pharmaceutical Market Share by Type in 2023
-
Figure China Antirheumatics Pharmaceutical Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Immunological Preparation (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Slow Acting Drug (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Production Volume and Growth Rate of Steroidal Anti-Inflammatory Drugs (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Market Share by Application in 2018
-
Figure China Antirheumatics Pharmaceutical Market Share by Application in 2023
-
Figure China Antirheumatics Pharmaceutical Total Market Size and Growth Rate from Consumption End
-
Figure China Antirheumatics Pharmaceutical Market Size and Growth Rate of Hospital and Clinic (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Market Size and Growth Rate of Pharmaceutical Industry (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Market Size and Growth Rate of Other (2018-2023)
-
Table China Antirheumatics Pharmaceutical Production Volume by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Production Volume Share by Region (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Production Volume Share by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Production Value by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Production Value Share by Region (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Production Value Share by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Sales Volume by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Sales Volume Share by Region (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Sales Volume Share by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Sales Value by Region (2018-2023)
-
Table China Antirheumatics Pharmaceutical Sales Value Share by Region (2018-2023)
-
Figure China Antirheumatics Pharmaceutical Sales Value Share by Region (2018-2023)
-
Table North China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table North China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure North China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table North China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table North China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure North China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table Central China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table Central China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure Central China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table Central China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table Central China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure Central China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table South China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table South China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure South China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table South China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table South China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure South China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table East China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table East China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure East China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table East China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table East China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure East China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table Northeast China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table Northeast China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure Northeast China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table Northeast China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table Northeast China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table Southwest China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table Southwest China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure Southwest China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table Southwest China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table Southwest China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table Northwest China Antirheumatics Pharmaceutical Production Volume by Type (2018-2023)
-
Table Northwest China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Figure Northwest China Antirheumatics Pharmaceutical Production Volume Share by Type (2018-2023)
-
Table Northwest China Antirheumatics Pharmaceutical Sales Volume by Application (2018-2023)
-
Table Northwest China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Antirheumatics Pharmaceutical Sales Volume Share by Application (2018-2023)
-
Table Novartis International AG Company Profile
-
Table Novartis International AG Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table UCB SA Company Profile
-
Table UCB SA Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
Table Roche Holding AG Company Profile
-
Table Roche Holding AG Antirheumatics Pharmaceutical Revenue, Price and Gross (2018-2023)
-
